Abstract: This application relates to nanoparticles, including nanoparticles derived from a plasma, and their use in the formation of conjugates. The nanoparticles can be stably conjugated to a wide variety of second species, forming conjugates which can be used, for example, in therapeutic, diagnostic and experimental methods.
Type:
Grant
Filed:
December 21, 2017
Date of Patent:
June 27, 2023
Assignee:
NANOMEDX, INC.
Inventors:
Miguel Angelo Correia Dos Santos, Elysse Filipe, Praveesuda Lorwattanapongsa, Marcela Bilek, Steven Garry Wise